Once the array reaches the skin, its needles create temporary openings through the stratum corneum, the skin’s outer barrier. Delivery can then be driven by applied pressure or by diffusion, allowing material to move through the internal bores toward selected skin layers. This mechanism supports localized treatment while limiting tissue disruption.
Pressure-driven delivery uses an applied force to move drugs or vaccines through the bores, whereas diffusion relies on movement across the pathway without that driving pressure. This distinction matters because the two mechanisms provide different ways to direct material through the array toward targeted skin layers during transdermal treatment.
Bioengineering development focuses on three linked issues: fabrication of the microscale structures, dosing accuracy, and integration with wearable sensing systems. Fabrication affects whether the array provides the intended hollow pathways, while dosing accuracy influences delivery reliability. Wearable integration can connect delivery or sampling with ongoing measurement, guiding further design refinement.
A basic workflow begins by placing the array against skin so the needles cross the stratum corneum. For delivery, pressure or diffusion moves a selected drug or vaccine through the hollow channels into a targeted layer. For sampling, the array instead enables extraction of interstitial fluid. The platform therefore supports both inward delivery and outward fluid collection.
Interstitial fluid extraction provides a route to biomarker analysis without limiting the array to therapeutic delivery. In bioengineering studies, researchers can examine the sampled diagnostic fluid after it is extracted through the hollow channels. This application broadens the platform from localized therapy to minimally invasive collection of biological information for analysis.
Their microscale format can reduce pain and improve patient acceptance while enabling localized delivery, controlled release, or interstitial-fluid sampling. These capabilities make the arrays relevant to transdermal drugs and vaccines as well as diagnostic approaches. Ongoing research also examines how they can be integrated with wearable sensing systems for combined delivery and measurement.